Clinical Pharmacology

Reducing the risk of heart disease

The division of Clinical Pharmacology is home to one of the oldest and most well-respected lipid clinics in the country. Our physicians, pharmacists and a licensed dietitian specialize in the prevention and treatment of conditions that can lead to atherosclerosis or hardening of the arteries, a major cause of heart disease. They provide aggressive treatment for:

  • High Cholesterol
  • Hypertension
  • Metabolic Syndrome
  • Obesity

The Most Progressive Treatment Options

Our physicians are recognized for their expertise in identifying disease in patients who have no current symptoms. They are the region's most experienced physicians in performing a diagnostic procedure called carotid intima-media thickness (IMT). This ultrasound test identifies early-stage thickening in the carotid artery, identifying risks before atherosclerosis occurs. Early diagnosis and treatment can reduce the risk of heart attack, stroke and sudden death.

The University of Kansas Hospital is the only hospital in Kansas or Missouri performing low-density lipoprotein (LDL) apheresis therapy, a highly effective treatment that removes harmful “bad” cholesterol from the blood within two hours. This therapy is an option for those who haven’t been able to control their LDL cholesterol with medication and diet modification.

National Research Leaders

Patients benefit from advanced research with the opportunity to participate in clinical trials for weight loss, abnormal cholesterol levels, metabolic syndrome and hypertension.

All of our physicians are faculty members at the University of Kansas School of Medicine. As experts in their fields, they teach medical students and residents the most effective methods to prevent and treat coronary artery disease.